Gastroparesis and Gastroenteritis Lead To Ozempic, Wegovy Lawsuits

Legal Cases Involving Ozempic Gain Momentum

As lawsuits over the popular drug Ozempic pile up across the United States, Novo Nordisk—the drug’s manufacturer—finds itself under increased scrutiny. Cases are also being filed for Wegovy under similar circumstances. Plaintiffs allege that they’ve suffered from severe health issues, including gastroparesis (stomach paralysis), chronic gastroenteritis, and ongoing vomiting. Accusations point to Novo Nordisk for not adequately disclosing these potential side effects, even as it promoted Ozempic for weight loss and generated billions in revenue.

Initial Lawsuit Against Novo Nordisk Filed

In August 2023, CNN and other reputable news outlets brought attention to a lawsuit asserting that Novo Nordisk was fully aware of these gastrointestinal risks but chose not to inform consumers. This particular legal action aims to obtain compensation for various damages, including emotional distress, physical suffering, and medical expenses incurred. Legal experts anticipate that this case could pave the way for a surge of similar lawsuits across the country.

What Exactly Is Ozempic?

Originally receiving FDA approval in 2017 as a medication for type 2 diabetes, Ozempic functions as a GLP-1 receptor agonist. This means it imitates the action of the naturally occurring hormone GLP-1, which both controls blood sugar levels and influences feelings of satiety.

Different Forms and Dosages

Ozempic and its relatives in the semaglutide family are available in a variety of formulations:

  • Ozempic: Administered as weekly injections, with doses ranging from 0.25mg to 2mg.
  • Wegovy: Another weekly injectable option, with dosages from 0.25mg up to 2.4mg.Rybelsus: A daily oral tablet that comes in 3mg, 7mg, or 14mg doses.

The Financial Burden

The monthly cost for Ozempic and Wegovy can be prohibitive, often falling between $1,000 and $1,700 when not covered by insurance. However, users report that the long-term health ramifications might end up being the more significant expense. For instance, Emily Wright, a teacher based in Toronto, experienced frequent vomiting that persisted even a year after discontinuing Ozempic, causing her to take an extended leave of absence from her job.

The Marketing Machine

Novo Nordisk has aggressively marketed Ozempic for its weight loss benefits, despite its original approval for diabetes treatment. In 2023 alone, the company allocated approximately $884 million for television advertising, boosting Ozempic’s prescription rates to record highs. The medication’s prominence even spilled over into social media and pop culture, creating a sense of mainstream acceptance.

Real-World Implications

However, this rosy picture is marred by stories from users who have suffered severe and sometimes life-altering complications. Joanie Knight and Brenda Allen, two women who used Ozempic, have shared harrowing experiences of ongoing health issues that persisted long after they stopped taking the medication.

Investigating the Side Effects

Several medical studies have linked Ozempic to worrying side effects. Legal documents filed against Novo Nordisk frequently cite these, including:

  • Gastroparesis: This involves a slowing down or complete halt of the stomach muscles, affecting the movement of food from the stomach to the small intestine.
  • Gastroenteritis: An inflammatory condition affecting the stomach and intestines, usually leading to symptoms like vomiting, diarrhea, and severe dehydration.

Gallbladder Complications Under the Microscope

Some researchers are beginning to suspect that GLP-1 receptor agonists like Ozempic might be linked to gallbladder problems. However, the mechanism behind this potential connection remains elusive and requires further study. As we gather more information on this topic, we will add to this page.

The Academic Consensus

Several meta-analyses suggest that GLP-1 receptor agonists may increase the risk of gallbladder and biliary diseases, especially when used at higher doses or over long periods. These findings are becoming increasingly important in the legal arguments against Ozempic and similar drugs.

On the Horizon: Class Action or Multidistrict Litigation?

As of now, no class-action lawsuit against Ozempic has been filed. However, given the increasing number of individual suits, the possibility of multidistrict litigation to consolidate these cases may arise. Currently, we are proceeding on injury cases on a case-by-case basis.

Ozempic and Mounjaro: A Comparative Perspective

Both Ozempic and Mounjaro are used in the management of type 2 diabetes. While Ozempic is now facing a storm of litigation for its severe side effects, some experts opine that Mounjaro may be linked to even more drastic complications.

Financial compensation in Ozempic Lawsuits

The amount of compensation in any given Ozempic lawsuit can vary significantly based on the specifics of the case and whether a settlement is reached out of court. In general, settlements could cover:

  • Past and future medical expenses
  • Loss of earnings
  • Emotional and physical pain and suffering

This unfolding legal drama is bound to continue evolving, with potential repercussions for the pharmaceutical industry and consumers.

Who Can File a Lawsuit Against Ozempic?

Anyone who has suffered from the side effects listed above after taking Ozempic may be eligible to file a lawsuit. However, eligibility often depends on factors like the severity of symptoms, the timing between taking the medication and the onset of symptoms, and whether other health conditions could have contributed to the complications.

To learn more about your legal rights, call us at (888) 818-8955 or complete our form below.